Objective: The purpose of this study was to investigate whether angiotensin II provokes ventricular tachyarrhythmias and to clarify its mechanism using the cesium-induced arrhythmia model, which has been widely used as an afterdepolarization and triggered activity model. Methods: Eighteen adult mongrel dogs of either sex weighing 9.6-23.0 kg were studied. The dogs were randomly divided into three groups. In the control group (n56), the subjects received intravenous saline solution at a 0.45 ml / kg / h, and intravenous bolus injections of cesium (0.25, 0.5, 1.0 mmol / kg) were given at 20-min intervals. In the captopril-treated group (n56), captopril was administered intravenously at 15 mg / kg / min, and cesium was injected as above. After the infusion of only captopril, in the captopril-treated group, angiotensin II was simultaneously infused at a dose of 0.1 ng / kg / min, and cesium was injected as above. When the dog survived, the dose of angiotensin II was increased to 1.0 ng / kg / min, and the same procedure was repeated. The remaining six dogs were simultaneously infused with captopril (15 mg / kg / min), angiotensin II (1.0 ng / kg / min), and U-73122 (10 mg / kg / min), a selective phospholipase C blocker, and injected with cesium (1.0 mmol / kg). Forty minutes after termination of U-73122 infusion, the dogs were injected with the same dose of cesium. Results: Sustained ventricular tachycardia or ventricular fibrillation was induced by cesium in all of the dogs in the control group. In the captopril-treated group, none of the dogs showed these arrhythmias when only captopril was infused. The treatment of captopril significantly reduced lethal arrhythmias (P,0.01 vs. control group). During the simultaneous infusion of captopril and angiotensin II (0.1 ng / kg / min), cesium produced sustained ventricular tachycardia in all six dogs and the arrhythmia developed into ventricular fibrillation in three dogs. By increasing the dose of angiotensin II (1.0 ng / kg / min), the surviving three dogs died following induced ventricular fibrillation. The additional infusion of angiotensin II (0.1 and 1.0 ng / kg / min) significantly increased fatal arrhythmias (P,0.01 vs. only captopril-infused period, respectively). None of the dogs in the third group exhibited ventricular tachycardia during the infusion of U-73122, and ventricular fibrillations were recorded in all six dogs in the absence of U-73122. The treatment of U-73122 significantly reduced lethal arrhythmias. (P,0.01 vs. control period). Conclusions: These results suggest that angiotensin II provokes cesium-induced ventricular tachyarrhythmias by increasing calcium release from sarcoplasmic reticulum in myocytes via activation of a phosphatidylinositol response.
Introduction
or myocardial infarction. Several open studies have indicated that treatment with captopril is beneficial [2] [3] [4] [5] [6] . This Severe congestive heart failure entails a heavy burden of agent has also been reported to have an anti-arrhythmic symptoms and carries a grave prognosis. Patients who effect [7, 8] . We previously demonstrated that losartan, an suffer from heart failure often show increased QT disperangiotensin II antagonist, had a beneficial effect on resion or a prolonged QT interval due to reduced potassium perfusion arrhythmia [9] . It is supposed that a non-reenchannel density [1] , and subsequently show ventricular trant mechanism such as triggered activity due to aftertachyarrhythmias. Captopril, an angiotensin-converting depolarizations is involved in the genesis of reperfusion enzyme (ACE) inhibitor, would be expected to offer all of arrhythmia [10] . Recently, the ELITE study [11] reported the advantages of conventional vasodilators in heart failure that losartan reduced sudden death in elderly heart failure patients. Brooksby et al. [12] explained that the mechanism *Corresponding author. Tel.: 181-92-801-1011 (3369); fax: 181-92-865-2692.
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0008-6363 / 01 / $ -see front matter © 2001 Elsevier Science B. V. All rights reserved. PII: S0008-6363( 00 )00249-2 of this protective effect might be related to a reduced QT ventricular endocardium with a bipolar contact catheter dispersion, which is an important arrhythmogenic factor.
with a silver-silver chloride distal electrode and a referAngiotensin II seems to initiate ventricular arrhythmias ence lead 5-mm away. The surface ECG of lead II and by increasing intracellular calcium, however the underlyMAPs were recorded simultaneously on a strip-chart ing mechanism is unclear. To test the hypothesis that recorder. Signals of MAPs were amplified and filtered at a angiotensin II provokes ventricular tachyarrhythmias due frequency of 0.04-500 Hz. Baseline recordings were to calcium overload, we investigated the effects of anobtained 10 min after placement of all electrodes and only giotensin II on ventricular arrhythmias using the cesiumwhen the MAP recording appeared to be stable and over induced arrhythmia model, which has been widely used as 10 mV with uniform morphology. The MAPD90 was a model of afterdepolarization and triggered activity measured as the interval between the beginning of depolar- [13, 14] .
ization and 90% repolarization of MAP. The MAPs were recorded before and after the injection of cesium in each state. We measured MAPD90 1 min after the injection of cesium when heart rate is controlled by atrial pacing (cycle 2. Methods length: CL5500 ms The experimental protocol is shown in Fig. 1 . The dogs 2.1. Experimental preparation were randomly divided into three groups of six dogs each.
In the control group, dogs received intravenous saline Eighteen adult mongrel dogs of either sex weighing solution at 0.45 ml / kg / h. After baseline recordings were 9.6-23.0 kg were used. The animals were anesthetized obtained, the dogs received an initial intravenous injection with pentobarbital sodium (25 mg / kg). After endotracheal of cesium (0.25 mmol / kg, dissolved in normal saline) over intubation, the dogs were ventilated with room air, oxygen, 15 s. Two additional injections were given at 20-min and halothan to maintain anesthesia by means of a Harvard intervals. The doses of the second and third injections of respirator. The tidal volume and respiratory rate were cesium were 0.5 and 1.0 mmol / kg, respectively (Fig. 1A ). adjusted to maintain the blood gases and pH within the In the captopril-treated group, captopril was administered physiologic range. Quadripolar 6-Fr catheter electrodes intravenously at 15 mg / kg / min [16] 40 min before the first with an interelectrode distance of 1 cm were advanced into cesium injection and continuously throughout the entire the right atrial appendage through the right internal jugular study to block endogenous angiotensin II formation. Three vein. Stimulation of the right atrial appendage was perinjections of cesium were administered as in the control formed with a distal pair of electrodes on the same group. Following the infusion of only captopril, angiotencatheter. A cardiac stimulator (Fukuda Denshi BC-02A) sin II was infused simultaneously at a dose of 0.1 ng / kg / was used to deliver square-wave impulses of twice the min for 40 min, and cesium injections were performed as diastolic threshold for atrial pacing. Bipolar recordings above. When the dog survived after the injection of were obtained from the right atrial appendage with a maximal dose (1.0 mmol / kg) of cesium, the dose of proximal pair of electrodes. Another bipolar catheter angiotensin II was increased to 1.0 ng / kg / min, and the electrode with an interelectrode distance of 5 mm was same procedure was repeated (Fig. 1B) . introduced through the left jugular vein and positioned
In the protocol shown in Fig. 1C , the dogs were within the right ventricular endocardium to record the simultaneously infused with captopril (15 mg / kg / min), monophasic action potential (MAP). Catheters were placed angiotensin II (1.0 ng / kg / min), and U-73122 (10 mg / kg / in the right femoral artery to monitor arterial blood min), a selective phospholipase C blocker, and then pressure and in the right femoral vein to infuse drugs and received an intravenous injection of cesium (1.0 mmol / normal saline (0.9%). The surface ECG of lead II, MAPs, kg). Forty minutes after the termination of U-73122 and arterial blood pressure were recorded on a strip chart infusion, the dogs were injected with the same dose of recorder (San Ei 8MI4) at paper speeds of 25-100 mm / s. cesium. The operating room was maintained at 20-228C through-
The following definitions were used for ventricular out the experimental procedure.
tachyarrhythmias induced by cesium injections: ventricular tachycardia (VT), three or more consecutive premature 2.2. Recording of MAPs ventricular beats; non-sustained VT (NSVT), VT terminating spontaneously within 30 s; sustained VT (SVT), VT Action potentials were recorded by the contact electrode persisting for .30 s; and ventricular fibrillation (VF), technique [15] . MAPs were recorded from the right rapid and irregular ventricular activity (rate.300 beats / min) and ineffective mechanical performance. We defined 3. Results SVT and VF as fatal arrhythmias.
Effects of captopril on hemodynamics, ECG variables and MAPD

Statistical analysis
Before the first cesium injection, none of the animals Data are expressed as the mean6S.D. unless specified showed ventricular arrhythmia on ECG, and all MAPs otherwise. Hemodynamics, ECG variables and MAPD data showed smooth repolarization. The effects of saline and were analyzed using a paired t-test and one-factor ANOVA captopril on hemodynamics, ECG variables and MAPD are ( Table 1 ). The prolongation ratios of QT interval and summarized in Table 1 . The six dogs in the control group MAPD90 were analyzed using unpaired t-test. The effects were infused with normal saline throughout the study. The of treatments on ventricular tachyarrhythmias were estisinus cycle length, systolic and diastolic arterial blood mated using Fisher's exact test . A P value of pressure, ECG variables including PQ, QRS and QT ,0.05 was considered significant. intervals and MAPD90 remained essentially unchanged by saline infusion. In the captopril-treated group, there was no (cycle length: CL5500 ms). At baseline, both groups significant difference in the sinus cycle length, three ECG showed smooth repolarization. In the control group, the variables and MAPD90 between baseline and only captopfirst injection of cesium (0.25 mmol / kg) slightly proril-infused period. In contrast, systolic blood pressure longed QT interval and MAPD, and the second injection significantly decreased from 11667.4 to 9967.4 mmHg (0.5 mmol / kg) produced longer QT interval and gentle (P,0.01 vs. baseline), and diastolic blood pressure sigrepolarization in MAP. The similar findings were seen in nificantly decreased from 8365.2 to 6765.2 mmHg (P, the captopril-treated group. The QT interval and MAPD 0.01 vs. baseline).
data from all of the dogs are shown in Table 2 . Cesium blocks diastolic inward depolarizing current [19] . It is 3.
Effects of cesium on QT interval, MAPD90 and
activated by hyperpolarization, which may be responsible ventricular tachyarrhythmias for initial phase of spontaneous depolarization in a sinus nodal pacemaker. Therefore, cesium decreased the heart Cesium blocks potassium channel currents, including rate in both groups. Atrial pacing (CL5500 ms) was inward rectifier potassium current [17, 18] , and prolongs performed to correct QT interval and MAPD90 by adjustthe monophasic action potential duration. The records of ing the cycle length, and the prolongation ratios of QT subjects in the control and captopril-treated groups are interval and MAPD90 by cesium injections (0.25 and 0.5 shown in Fig. 2 , in which atrial pacing was performed mmol / kg) were evaluated. There was no significant differ- Fig. 2 . Effect of the first and second bolus injection of cesium (0.25 and 0.5 mmol / kg, respectively) on the EGG (lead II) and the MAP of the right ventricular endocardium in a dog of the control group (upper panel) and the other subject of the captopril-treated group (lower panel). In upper panel, the MAP was recorded with smooth repolarization before the injection of cesium. The first injection of cesium slightly prolonged QT interva1 and MAP duration. The second injection of cesium produced longer QT interval and gentle repolarization in MAP. The similar findings were observed in the captopril-treated group. In this figure, the experiment was carried out when heart rate was controlled by atrial pacing (CL5500 ms). ence in any variables among the four states. Therefore, we nificantly reduced incidence of fatal arrhythmias induced concluded that the inhibition of angiotensin II formation by maximal dose of cesium (P,0.01 vs. control group). had no action on the potassium channel-blocking effect. Fig. 3 shows the recordings illustrating the effect of maximal dose of cesium. About 20 s after the injection of 3.3. Effects of angiotensin II on hemodynamics, ECG cesium (1.0 mmol / kg), VF following VT occurred in the variables and MAPD control group (Fig. 3B) . In contrast, in the captopril-treated group the same dose of cesium produced only premature
The effects of angiotensin II on hemodynamics, ECG atrial and ventricular contractions, but not VT (Fig. 3A) .
variables and MAPD90 are summarized in Table 1 . There  Fig. 4 compares the incidence and patterns of ventricular was no significant difference in three ECG variables, tachyarrhythmias in the control and captopril-treated MAPD90 between baseline and each angiotensin-infused groups. Ventricular tachyarrhythmias were recorded during (0.1 and 1.0 ng / kg / min) period. As stated above, systolic three 20-min intervals after cesium injection. In this figure, and diastolic arterial blood pressure significantly decreased when more than two types of ventricular tachyarrhythmias in the only captopril-infused period compared with appeared in a single observation period, the highest grade baseline, however, there was no significant difference was counted. Although premature ventricular contractions between baseline and each angiotensin-infused period. The were recorded in several dogs in both the control and sinus cycle length significantly increased in each angiotencaptopril-treated groups following the injection of the sin-infused period compared with baseline. This is probaminimal dose of cesium (0.25 mmol / kg), they were not bly due to the remaining blocking of diastolic inward counted in this figure. The second injection of cesium (0.5 depolarizing current by cesium administered in the only mmol / kg) produced NSVT in two subjects and SVT in captopril-infused period. In the same way as the only one subject in the control group, but no VT in the captopril-infused period, the prolongation ratios of QT captopril-treated group. The maximal dose of cesium (1.0 interval and MAPD90 by cesium injections (0.25 and 0.5 mmol / kg) produced SVT or VF in all of the six subjects in mmol / kg) were evaluated ( Table 2 ). There was no signifithe control group, but in none of the six subjects in the cant difference in any variables between baseline and each captopril-treated group. The treatment of captopril sigangiotensin-infused period. Accordingly, we considered that angiotensin II did not affect the potassium channelincreased fatal arrhythmias induced by maximal dose of blocking effect. cesium (P,0.01 vs. only captopril-infused period).
Anti-arrhythmic effect of phospholipase C blocker 3.4. Infusion of angiotensin II provokes ventricular tachyarrhythmias
Although captopril did not improve the prolongation of MAPD90, it did have an anti-arrhythmic effect. AngiotenThe prevalence of inducible ventricular tachyarsin II is known to bind to AT1 receptor and activate rhythmias in the only captopril-infused, captopril and low phospholipase C, which hydrolyzes phosphatidylinositoldose of angiotensin II-infused and captopril and high dose 4,5-biphosphate (PIP2) to form myoinositol-1,4,5-triphosof angiotensin II-infused periods is summarized in Fig. 5 .
phate (IP3) and diacylglycerol. The availability of IP3 When more than two types of tachyarrhythmias appeared leads to an increase in the cytosolic calcium concentration in a single observation period, they were treated as in Fig. from the sarcoplasmic reticulum. Therefore, we hypoth-4. NSVT was recorded in three of the six subjects with 1.0 esized that the inhibition of endogenous angiotensin II mmol / kg cesium in the only captopril-infused period, and formation by captopril would attenuate calcium release all of the subjects survived. During the infusion of from sarcoplasmic reticulum, and subsequently suppress angiotensin II (0.1 ng / kg / min), 0.5 mmol / kg cesium the genesis of malignant ventricular tachyarrhythmias. The caused NSVT in two dogs and SVT in one. The third purpose of this experiment was to examine whether Uinjection (1.0 mmol / kg cesium) produced SVT in all six 73122, a selective phospholipase C blocker, can mimic dogs, and the arrhythmia developed into VF in three captopril with respect to its anti-arrhythmic effect. The animals, which subsequently died. With an increased dose protocol is shown in Fig. 1C . of angiotensin II (1.0 ng / kg / min), one and two dogs died Infusion of U-73122 did not affect the sinus cycle following VF induced by 0.5 and 1.0 mmol / kg cesium, length, ECG variables and MAPD90 (data not shown), respectively. The additional infusion of angiotensin II (0.1 whereas both the systolic and diastolic arterial blood and 1.0 ng / kg / min) had proarrhythmic effect on the lower pressure decreased significantly during the infusion of dose of cesium-induced arrhythmias, and significantly U-73122 compared with baseline (SBP; from 11968.6 to Fig. 5 . Prevalence of ventricular tachyarrhythmias during three repetitive injections of cesium in the only captopril-infused, captopril and low dose of angiotensin ll-infused and captopril and high dose of angiotensin II had proarrhythmic effect on lower dose of cesium-induced arrhythmia. Additionally, the high and low dose of angiotensin II significantly increased incidence of sustained ventricular tachycardia or a more severe grade of arrhythmia induced by the maximal dose of cesium (P,0.01 vs. only captopril-infused period, respectively).
C blocker, had an anti-arrhythmic effect similar to that of captopril. Thus, these are the first findings to suggest that angiotensin II contributes to cesium-induced tachyarrhythmias by increasing calcium release from sarcoplasmic reticulum in myocytes via activation of a phosphatidylinositol response.
Previous studies on the anti-arrhythmic effect of an ACE inhibitor
Previous studies have shown that treatment with captopril has various beneficial effects on ventricular arrhythmias [7, 8] . For example, Cleland et al. [7] observed that longterm treatment with captopril reduced ventricular arrhythmias in patients who suffered from congestive heart failure, and Kingma et al. [8] demonstrated that intraven- release of catecholamine is an important arrhythmogenic factor. Indeed, the decrease in catecholamine may play a 9868.2 mmHg, DBP; from 8666.6 to 6864.1 mmHg).
role in the mechanism of this improvement. In our Vasodilatation induced by the reduction of calcium release experimental model, however, there may not be excessive from sarcoplasmic reticulum in vascular smooth muscle local release of catecholamine as in reperfusion or postcells might account for this decrease in arterial blood infarct models. Therefore, we did not regard inhibition of pressure.
the local release of catecholamine as the main mechanism The injection of cesium produced isolated premature of the anti-arrhythmic effect of captopril. Several invesventricular contractions, but VT was never recorded during tigators have reported that angiotensin II shortened the the infusion of U-73122. In the same dog, however, the duration of monophasic action potential [20] , and that same dose of cesium induced lethal ventricular arrhythmia enalapril, an ACE inhibitor, prolonged this duration [21] . 40 min after termination of the infusion of U-73122. Fig. 6 As shown in Tables 1 and 2 , however, our observations compares the incidence of ventricular tachyarrhythmias revealed that both captopril and angiotensin II did not between the U-73122-infused period and the control significantly change QT interval and MAPD90. In addiperiod. None of the six dogs presented VT during the tion, these agents had no effect on the prolongation of QT infusion of U-73122, whereas VF occurred in all of the six interval and MAPD90 by the injection of cesium. Accordsubjects in the control period. The treatment of U-73122 ingly, the effect on the action potential duration cannot significantly reduced the incidence of fatal ventricular account for the anti-arrhythmic action of an ACE inhibitor. arrhythmia by the injection of cesium (1.0 mmol / kg) (P,0.01 vs. control period). Thus, a selective phospholip-4.3. Contribution of phosphatidylinositol-phospholipase ase C blocker had an anti-arrhythmic effect like an ACE C pathways to ventricular tachyarrhythmias inhibitor.
Several investigators have reported that cesium-induced ventricular tachyarrhythmias are modulated by some drugs 4. Discussion or the stimulation of autonomic nerves [22, 23] . Takahashi et al. [22] observed that vagal stimulation suppressed the 4.1. Main findings genesis of ventricular arrhythmias. Iwao et al.
[23] demonstrated that sustained stimulation of the left ansae subIn this study, captopril, which blocks endogenous anclaviae for 5 h inhibited this arrhythmia. They suggested giotensin II formation, attenuated the risk of developing that this protective effect might be partially explained by ventricular tachyarrhythmias induced by the intravenous desensitization to b-adrenergic stimulation. In addition, injection of cesium without improving the prolongation of David and Zipes [24] showed that a1 -adrenoceptor QT interval and MAPD, and exogenous angiotensin II stimulation increased, and a -adrenoceptor blockade deprovoked fatal ventricular tachyarrhythmias. Additionally, creased, the incidence of cesium-induced VT in dogs. They we demonstrated that U-73122, a selective phospholipase proposed that the mechanism might be related, in part, to an increase in the cytosolic calcium concentration. Activaidentified in human hearts [32] . We used captopril, which tion of the a1-adrenoceptor is postulated to activate an was angiotensin-converting enzyme inhibitor, to inhibit enzyme, phospholipase C, which hydrolyzes PIP2 to form endogenous angiotensin II formation. Therefore, angioten-IP3 and diacylglycerol [25] . The availability of IP3 leads sin II production could not be completely blocked. During to an increase in the cytosolic calcium concentration the infusion of captopril and angiotensin II, we observed [26, 27] , in some tissues directly from the sarcoplasmic the effect of endogenous angiotensin II via the reninreticulum [28] . Angiotensin II is known to activate phosangiotensin system independent pathways plus infused pholipase C like a1-adrenoceptor stimulation [29] . Acangiotensin II from outside. To block endogenous ancordingly, we suggest that the inhibition of angiotensin II giotensin II completely, angiotensin II antagonist should formation may have an anti-arrhythmic effect by attenuatalso be administered in a future study. ing the increase in the cytosolic calcium concentration.
The beneficial effects of ACE inhibitors on the longterm prognosis of patients after congestive heart failure 4. 4 
. Study limitations and clinical implications
have been clearly demonstrated [3, 4] . Although the mechanisms of these effects may involve many factors, suppresOne of the limitations of the present study might be the sion of the cardiac renin-angiotensin system may make an manner in which captopril was administered. Although important contribution to the cardiac effects of ACE intravenous infusion was used in the present study, longinhibitors. We have shown that angiotensin II contributes term oral treatment might be necessary to determine the to the genesis of lethal ventricular tachyarrhythmias. efficacy of this drug on ventricular tachyarrhythmias in Therefore, an ACE inhibitor or angiotensin II antagonist humans. Another concern is the failure to compare the may help protect against malignant ventricular tachyarprolongation ratios of QT interval and MAPD90 by the rhythmias induced by triggered activity. Furthermore, it injection of maximal dose (1.0 mmol / kg) of cesium in the might be worthwhile to develop a selective cardiac phoscontrol and captopril-treated groups. Because most of the pholipase C blocker, which dose not affect vascular control animals showed VT just after injection of the smooth muscle, to maintain an appropriate systemic arterimaximal dose of cesium, we could not measure the QT al blood pressure and treat ventricular tachyarrhythmias. interval and MAPD90 with atrial pacing. Therefore, the prolongation ratios of the QT interval and MAPD90 by lower doses of cesium (0.25 and 0.5 mmol / kg) were References evaluated. Thirdly, since we did not measure MAPD of the M-cell, which seemed to be more sensitive to potassium
